Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Greif
GEF
$5.03B
| $4.48M | ﹤0.01% |
69,009
+20,433
| +42% | +$1.16M |
|
2202
Adient
ADNT
$1.54B
| $4.47M | ﹤0.01% |
229,530
+40,144
| +21% | +$593K |
|
|
PRMB
2203
CALL
Primo Brands
PRMB
$8.97B
| $4.45M | ﹤0.01% |
+150,200
| New | +$4.8M |
|
2204
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $4.44M | ﹤0.01% |
61,127
-60,253
| -50% | -$4.08M |
|
2205
Supernus Pharmaceuticals
SUPN
$2.74B
| $4.44M | ﹤0.01% |
140,939
+40,929
| +41% | +$1.31M |
|
2206
CALL
Lam Research
LRCX
$422B
| $4.44M | ﹤0.01% |
45,600
-30,100
| -40% | -$2.39M |
|
2207
OneSpaWorld
OSW
$2.73B
| $4.43M | ﹤0.01% |
217,408
+43,746
| +25% | +$802K |
|
2208
Ligand Pharmaceuticals
LGND
$5.76B
| $4.43M | ﹤0.01% |
38,981
+14,131
| +57% | +$1.51M |
|
2209
Powell Industries
POWL
$7.43B
| $4.43M | ﹤0.01% |
63,105
+18,603
| +42% | +$1.12M |
|
2210
Martin Midstream Partners
MMLP
$89.6M
| $4.42M | ﹤0.01% |
1,500,000
| – | – |
|
2211
TripAdvisor
TRIP
$1.29B
| $4.42M | ﹤0.01% |
338,562
+308,209
| +1,015% | +$4.12M |
|
2212
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
| $4.41M | ﹤0.01% |
140,371
+43,154
| +44% | +$1.44M |
|
2213
PUT
Roku
ROKU
$22.9B
| $4.41M | ﹤0.01% |
50,200
-57,000
| -53% | -$3.98M |
|
2214
PUT
Woodward
WWD
$21.2B
| $4.41M | ﹤0.01% |
+18,000
| New | +$3.68M |
|
2215
Acuity Brands
AYI
$10.8B
| $4.41M | ﹤0.01% |
14,776
-408
| -3% | -$106K |
|
|
SNDK
2216
Sandisk
SNDK
$223B
| $4.41M | ﹤0.01% |
97,138
+41,769
| +75% | +$1.6M |
|
2217
Cogent Communications
CCOI
$530M
| $4.4M | ﹤0.01% |
91,299
+29,954
| +49% | +$1.52M |
|
2218
Steven Madden
SHOO
$3.46B
| $4.39M | ﹤0.01% |
183,234
+83,956
| +85% | +$1.97M |
|
2219
TAL Education Group
TAL
$6.43B
| $4.39M | ﹤0.01% |
429,406
-557,312
| -56% | -$5.76M |
|
2220
Benchmark Electronics
BHE
$2.89B
| $4.38M | ﹤0.01% |
112,883
+10,248
| +10% | +$375K |
|
|
NXRT
2221
NexPoint Residential Trust
NXRT
$636M
| $4.38M | ﹤0.01% |
131,359
+20,975
| +19% | +$743K |
|
2222
CoreCivic
CXW
$3.13B
| $4.37M | ﹤0.01% |
207,498
+65,433
| +46% | +$1.41M |
|
2223
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $4.37M | ﹤0.01% |
93,377
+29,824
| +47% | +$1.22M |
|
2224
Corcept Therapeutics
CORT
$11.9B
| $4.36M | ﹤0.01% |
59,362
-67,089
| -53% | -$4.86M |
|
2225
Tidewater
TDW
$4.55B
| $4.35M | ﹤0.01% |
94,318
+37,007
| +65% | +$1.5M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.